C11ORF46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.432740E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.250200E-02
Normal-vs-Stage2
1.029560E-04
Normal-vs-Stage3
4.074500E-02
Normal-vs-Stage4
1.926790E-01
Stage1-vs-Stage2
2.796600E-01
Stage1-vs-Stage3
1.661610E-01
Stage1-vs-Stage4
7.889800E-01
Stage2-vs-Stage3
3.226200E-01
Stage2-vs-Stage4
2.091800E-01
Stage3-vs-Stage4
2.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.216000E-04
Normal-vs-AfricanAmerican
3.884000E-02
Normal-vs-Asian
1.257090E-03
Caucasian-vs-AfricanAmerican
8.618200E-01
Caucasian-vs-Asian
1.974820E-01
AfricanAmerican-vs-Asian
2.705800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.556880E-04
Normal-vs-Female
4.841600E-04
Male-vs-Female
1.820030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.233500E-02
Normal-vs-Age(41-60Yrs)
9.390000E-04
Normal-vs-Age(61-80Yrs)
2.153500E-04
Normal-vs-Age(81-100Yrs)
2.202600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.887600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.994600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.714000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.947800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.938400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.857400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.809090E-04
Normal-vs-Daily Drinker
1.123750E-01
Normal-vs-Weekly Drinker
1.055000E-01
Normal-vs-Occasional Drinker
1.890090E-02
Normal-vs-Social Drinker
2.697600E-02
Non Drinker-vs-Daily Drinker
4.312200E-01
Non Drinker-vs-Weekly Drinker
2.678000E-01
Non Drinker-vs-Occasional Drinker
4.949900E-02
Non Drinker-vs-Social Drinker
5.328300E-02
Daily Drinker-vs-Weekly Drinker
6.199600E-01
Daily Drinker-vs-Occasional Drinker
1.117860E-02
Daily Drinker-vs-Social Drinker
1.241860E-02
Weekly Drinker-vs-Occasional Drinker
1.400310E-02
Weekly Drinker-vs-Social Drinker
1.554160E-02
Occasional Drinker-vs-Social Drinker
9.499600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.837600E-02
Normal-vs-Grade 2
5.655600E-03
Normal-vs-Grade 3
6.443600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.730000E-01
Grade 1-vs-Grade 3
6.435600E-01
Grade 1-vs-Grade 4
2.837600E-02
Grade 2-vs-Grade 3
2.473800E-01
Grade 2-vs-Grade 4
5.655600E-03
Grade 3-vs-Grade 4
6.443600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.976400E-04
Normal-vs-NonDiabetic
6.07479999999994E-05
Diabetic-vs-NonDiabetic
6.243600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.735440E-03
Normal-vs-NoPancreatitis
8.37500000000491E-05
Pancreatitis-vs-NoPancreatitis
5.408200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.096800E-03
Normal-vs-N1
1.173010E-04
N0-vs-N1
4.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.824770E-01
Normal-vs-TP53-NonMutant
2.353200E-01
TP53-Mutant-vs-TP53-NonMutant
1.081230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
